Multi-Omics Analyses Identify Signatures in Patients with Liver Cirrhosis and Hepatocellular Carcinoma
Gut bacterial/viral dysbiosis, changes in circulating metabolites, and plasma cytokines/chemokines have been previously associated with various liver diseases. Here, we analyzed the associations between fecal microbial composition, circulating metabolites, and plasma cytokines/chemokines in patients...
Main Authors: | Ming-Wei Lai, Yu-De Chu, Chao-Wei Hsu, Yi-Cheng Chen, Kung-Hao Liang, Chau-Ting Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/1/210 |
Similar Items
-
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis
by: Da Jung Kim, et al.
Published: (2019-10-01) -
Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
by: Emidio Scarpellini, et al.
Published: (2020-08-01) -
Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis
by: Bei Gao, et al.
Published: (2022-01-01) -
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
by: Ruipeng Zheng, et al.
Published: (2020-06-01) -
Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
by: Boram Kim, et al.
Published: (2020-09-01)